PHAT insider transaction filings
Phathom Pharmaceuticals, Inc. — 50 most recent Form 4 filings from SEC EDGAR, normalized by FilingPulse. Latest filing: 2026-07-16. Screen PHAT transaction legs live →
| Filed | Form | Insider | Reported transactions | Source |
|---|---|---|---|---|
| 2026-07-16 | 4 | Breedlove Robert Charles — Principal Accounting Officer | Tax withholding (F): 1,555 @ $11.04 | EDGAR |
| 2026-05-27 | 4 | Parikh Asit — Director | Gift (G): 28,000 @ $0 · Gift (G): 28,000 @ $0 | EDGAR |
| 2026-05-21 | 4 | Parikh Asit — Director | Grant/award (A): 24,122 @ $0 · Option exercise (M): 17,500 @ $4.95 · Disposition to issuer (D): 17,500 (derivative) @ $0 | EDGAR |
| 2026-05-21 | 4 | Stenhouse Mark — Director | Grant/award (A): 24,122 @ $0 | EDGAR |
| 2026-05-21 | 4 | Schroeder Theodore R — Director | Grant/award (A): 24,122 @ $0 | EDGAR |
| 2026-05-21 | 4 | Topper James N — Director, 10% owner | Grant/award (A): 24,122 @ $0 | EDGAR |
| 2026-05-21 | 4 | KARBE FRANK — Director | Grant/award (A): 24,122 @ $0 | EDGAR |
| 2026-05-21 | 4 | COLA MICHAEL F — Director | Grant/award (A): 24,122 @ $0 | EDGAR |
| 2026-05-21 | 4 | FIELDS HEIDI — Director | Grant/award (A): 24,122 @ $0 | EDGAR |
| 2026-03-11 | 4 | Parikh Asit — Director | Gift (G): 40,000 @ $0 · Gift (G): 40,000 @ $0 | EDGAR |
| 2026-03-03 | 4 | Breedlove Robert Charles — Principal Accounting Officer | Grant/award (A): 13,000 @ $0 · Grant/award (A): 2,790 @ $0 · Tax withholding (F): 964 @ $12.56 · Tax withholding (F): 414 @ $12.56 | EDGAR |
| 2026-02-12 | 4 | Basta Steven L — President and CEO, Director | Grant/award (A): 12,362 @ $0 · Tax withholding (F): 6,277 @ $12.82 | EDGAR |
| 2026-02-12 | 4 | Cook Anne Marie — Chief Legal Off. & Corp. Sec. | Grant/award (A): 3,461 @ $0 · Tax withholding (F): 1,535 @ $12.82 | EDGAR |
| 2026-01-27 | 4 | Parikh Asit — Director | Gift (G): 80,500 @ $0 · Gift (G): 80,500 @ $0 | EDGAR |
| 2026-01-23 | 4 | Breedlove Robert Charles — Principal Accounting Officer | Tax withholding (F): 776 @ $13.61 | EDGAR |
| 2026-01-15 | 4 | Parikh Asit — Director | Option exercise (M): 8,750 @ $10.30 · Option exercise (M): 8,750 (derivative) @ $0 | EDGAR |
| 2026-01-02 | 4 | Narula Sanjeev — Chief Financial & Bus. Officer | Grant/award (A): 82,715 @ $0 · Grant/award (A): 42,848 (derivative) @ $0 | EDGAR |
| 2026-01-02 | 4 | Basta Steven L — President and CEO, Director | Grant/award (A): 251,034 @ $0 · Grant/award (A): 226,156 (derivative) @ $0 | EDGAR |
| 2026-01-02 | 4 | Cook Anne Marie — Chief Legal Off. & Corp. Sec. | Grant/award (A): 75,345 @ $0 · Grant/award (A): 67,878 (derivative) @ $0 | EDGAR |
| 2025-12-23 | 4 | Parikh Asit — Director | Option exercise (M): 8,750 @ $10.30 · Option exercise (M): 8,750 (derivative) @ $0 | EDGAR |
| 2025-12-19 | 4 | Breedlove Robert Charles — Principal Accounting Officer | Tax withholding (F): 230 @ $16.28 | EDGAR |
| 2025-12-19 | 4 | Basta Steven L — President and CEO, Director | Grant/award (A): 62,038 @ $0 · Tax withholding (F): 31,502 @ $15.36 | EDGAR |
| 2025-12-19 | 4 | Cook Anne Marie — Chief Legal Off. & Corp. Sec. | Grant/award (A): 17,370 @ $0 · Tax withholding (F): 7,703 @ $15.36 | EDGAR |
| 2025-12-02 | 4 | Basta Steven L — President and CEO, Director | Option exercise (M): 90,000 @ $0 · Tax withholding (F): 48,375 @ $15.62 · Option exercise (M): 90,000 (derivative) @ $0 | EDGAR |
| 2025-11-05 | 4 | Breedlove Robert Charles — Principal Accounting Officer | Sale (S): 524 @ $13.51 | EDGAR |
| 2025-10-08 | 4/A | Narula Sanjeev — Chief Financial & Bus. Officer | Grant/award (A): 144,000 @ $0 | EDGAR |
| 2025-10-07 | 4 | Narula Sanjeev — Chief Financial & Bus. Officer | Grant/award (A): 200,000 (derivative) @ $0 | EDGAR |
| 2025-09-26 | 4 | Basta Steven L — President and CEO, Director | Option exercise (M): 90,000 @ $0 · Tax withholding (F): 48,375 @ $11.66 · Option exercise (M): 90,000 (derivative) @ $0 | EDGAR |
| 2025-09-09 | 4 | Breedlove Robert Charles — Principal Accounting Officer | Sale (S): 461 @ $12.09 | EDGAR |
| 2025-07-18 | 4 | Breedlove Robert Charles — Principal Accounting Officer | Sale (S): 1,692 @ $8.36 | EDGAR |
| 2025-06-24 | 4 | Cook Anne Marie — Chief Legal Off. & Corp. Sec. | Grant/award (A): 210,000 (derivative) @ $0 | EDGAR |
| 2025-06-05 | 4 | Parikh Asit — Director | Grant/award (A): 10,500 @ $0 · Grant/award (A): 17,500 (derivative) @ $0 | EDGAR |
| 2025-06-05 | 4 | Stenhouse Mark — Director | Grant/award (A): 10,500 @ $0 · Grant/award (A): 17,500 (derivative) @ $0 | EDGAR |
| 2025-06-05 | 4 | Topper James N — Director, 10% owner | Grant/award (A): 10,500 @ $0 · Grant/award (A): 17,500 (derivative) @ $0 | EDGAR |
| 2025-06-05 | 4 | KARBE FRANK — Director | Grant/award (A): 10,500 @ $0 · Grant/award (A): 17,500 (derivative) @ $0 | EDGAR |
| 2025-06-05 | 4 | COLA MICHAEL F — Director | Grant/award (A): 10,500 @ $0 · Grant/award (A): 17,500 (derivative) @ $0 | EDGAR |
| 2025-06-05 | 4 | FIELDS HEIDI — Director | Grant/award (A): 10,500 @ $0 · Grant/award (A): 17,500 (derivative) @ $0 | EDGAR |
| 2025-05-23 | 4 | Topper James N — Director | Purchase (P): 3,780 @ $3.86 | EDGAR |
| 2025-05-21 | 4 | Breedlove Robert Charles — Principal Accounting Officer | Grant/award (A): 33,000 (derivative) @ $0 | EDGAR |
| 2025-05-15 | 4 | Topper James N — Director | Purchase (P): 1,120 @ $3.16 · Purchase (P): 6,300 @ $3.32 | EDGAR |
| 2025-05-13 | 4 | Topper James N — Director | Purchase (P): 33,376 @ $3.19 · Purchase (P): 2,226 @ $3.62 · Purchase (P): 12,601 @ $3.04 | EDGAR |
| 2025-05-08 | 4 | Parikh Asit — Director | Purchase (P): 5,000 @ $2.60 · Purchase (P): 5,000 @ $2.40 | EDGAR |
| 2025-04-16 | 4 | Schroeder Theodore R — Director | Grant/award (A): 21,000 @ $0 · Grant/award (A): 35,000 (derivative) @ $0 | EDGAR |
| 2025-04-08 | 4 | Henderson Molly — CFO and CBO | Sale (S): 3,678 @ $4.55 | EDGAR |
| 2025-04-03 | 4 | Basta Steven L — President and CEO, Director | Grant/award (A): 360,000 (derivative) @ $0 · Grant/award (A): 1,085,000 (derivative) @ $0 | EDGAR |
| 2025-03-21 | 4 | Parikh Asit — Director | Option exercise (M): 7,500 @ $11.72 · Option exercise (M): 7,500 (derivative) @ $0 | EDGAR |
| 2025-03-17 | 4 | Parikh Asit — Director | Purchase (P): 10,000 @ $4.42 | EDGAR |
| 2025-03-03 | 4 | Nabulsi Azmi — Chief Operating Officer | Grant/award (A): 79,200 @ $0 · Grant/award (A): 55,000 (derivative) @ $0 | EDGAR |
| 2025-03-03 | 4 | Curran Terrie — President and Chief Executive, Director | Grant/award (A): 342,500 (derivative) @ $0 | EDGAR |
| 2025-03-03 | 4 | Henderson Molly — CFO and CBO | Grant/award (A): 72,000 @ $0 · Grant/award (A): 50,000 (derivative) @ $0 | EDGAR |
Recent 8-K events — Phathom Pharmaceuticals, Inc.
| Filed | Form | Items reported | Source |
|---|---|---|---|
| 2026-07-30 | 8-K | 2.02 — Results of Operations and Financial Condition 9.01 — Financial Statements and Exhibits | EDGAR |
| 2026-06-23 | 8-K | 8.01 — Other Events | EDGAR |
| 2026-05-21 | 8-K | 5.07 — Submission of Matters to a Vote of Security Holders | EDGAR |
| 2026-04-30 | 8-K | 2.02 — Results of Operations and Financial Condition 9.01 — Financial Statements and Exhibits | EDGAR |
| 2026-02-26 | 8-K | 2.02 — Results of Operations and Financial Condition 9.01 — Financial Statements and Exhibits | EDGAR |
| 2026-01-08 | 8-K | 8.01 — Other Events 9.01 — Financial Statements and Exhibits | EDGAR |
| 2026-01-07 | 8-K | 2.02 — Results of Operations and Financial Condition 9.01 — Financial Statements and Exhibits | EDGAR |
| 2025-11-04 | 8-K | 8.01 — Other Events | EDGAR |
| 2025-10-30 | 8-K | 2.02 — Results of Operations and Financial Condition 9.01 — Financial Statements and Exhibits | EDGAR |
| 2025-10-27 | 8-K | 8.01 — Other Events | EDGAR |
Need this as JSON?
GET https://api.filingpulse.io/v1/insider-trades?ticker=PHAT returns every filing on this page — normalized, with footnotes and derivative legs — and webhooks push new ones to you in seconds. API docs →